WO2003011891A1 - A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes - Google Patents

A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes Download PDF

Info

Publication number
WO2003011891A1
WO2003011891A1 PCT/IN2001/000142 IN0100142W WO03011891A1 WO 2003011891 A1 WO2003011891 A1 WO 2003011891A1 IN 0100142 W IN0100142 W IN 0100142W WO 03011891 A1 WO03011891 A1 WO 03011891A1
Authority
WO
WIPO (PCT)
Prior art keywords
betulinic acid
acid
extracting
isolation
rhizomes
Prior art date
Application number
PCT/IN2001/000142
Other languages
French (fr)
Inventor
Pulok Kumar Mukherjee
Manjusree Pal
Bishnu Pada Saha
Original Assignee
Council Of Scientific And Industrial Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Of Scientific And Industrial Research filed Critical Council Of Scientific And Industrial Research
Priority to PCT/IN2001/000142 priority Critical patent/WO2003011891A1/en
Publication of WO2003011891A1 publication Critical patent/WO2003011891A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Definitions

  • the present invention relates to a process for the isolation of betulinic acid. More particularly, the present invention relates to a process for the isolation of betulinic acid from Nelumbo n ⁇ cifera Gaertn. (Family Nymphaeaceae). The acid thus obtained has potent therapeutic activity and is useful as anti-HIV, anti-tumoral and melanoma specific cytotoxic agent. Background of the invention
  • Nelumbo nucifera Gaertn. (Family Nymphaeaceae) is a large aquatic herb with slender elongate, branched creeping stems and stout creeping yellowish white coloured rhizomes.
  • the flower of Nelumbo nucifera Gaertn. is the national flower of India. Almost all parts of this plant are used in Indian Traditional Medicine to cure several diseases [Chopra, R. N., Chopra I. C, and Handa, K. L. (1958), Extra Drugs of India, 2 nd ed., U. N. Dhur & Sons Pvt. Ltd., Calcutta, p. 679; Kirtikar, K. R, and Basu, B.
  • Betulinic acid has been isolated and identified from several plant species.
  • the hexane extract of Picramnia pentandra showed the presence of 3 - epi-betulinic acid [Herz, W., Santhanam, P. S., and Wahlberg, I., (1972), Phytochemistry, Vol. 11, pp. 3061 - 3063].
  • the plants Lemaireocereus stellatus, L. pruinosus, Machaereocereus eruca have been found to contain oleanolic acid, betulinic acid and machaeric acid (21 - keto-oleanolic acid) [Djerassi, C, Liu, L. H., Farkar, E., Lippman, A.
  • Oleanolic acid, betulin, betulinic acid, erythrodiol, maniladiol and several other triterpenes have been isolated from cactus species along with some other cactus triterpenes such as longispinogenin, gummosogenin and cochalic acid, all belonging to the Cactaceae family.
  • Oleanolic acid and betulinic acid have also been isolated from several plants of the Lemaireocereus specie such as Lemaireocereus quovedonis, L. griseus, L. hystrix, L. treleasei.
  • petriel and A. whitei and of the wood, bark and leaves of A. macrocarpa are reported to possess triterpenes like betulinic acid, ceanothic acid and alphitolic acid [Branch, G. B., Buragers, D. V., Dunstan, P. J., Foo, L. Y., Green, G. H., Mack, J. P. G., Ritchie, E, and Taylor, W. C, (1972), Aust. J. Chem., Vol. 25, pp. 2209 - 2216].
  • the bark of Akania luceus (commonly known as 'turnip wood') has been found to contain betulinic acid, betulonic acid and 3— desoxy betulonic acid [Krajniak, E., Ritchie, E., and Taylor, W. C, (1969), Aust. J. Chem., Vol. 22, ppl331 - 1332].
  • the trunk wood of Caraipa grandifolia Mart (Family - Guttiferae) contains sitosterol, lupeol, lupenone, betulinic acid and vanillin.
  • densiflora Mart contains sitosterol, lupeol, friedelin, betulinic acid and vanillin [Alves De Lima, R., and Gottlieb, O. R., (1972), Phytochemistry, Vol. 11, pp. 2307 - 2309].
  • Betulinic acid and ursolic acid have been isolated from Hedyotis chrystoricha (Palib) Merr [Fang, Z., Yang, Y., and Zhou, G., (1992), Merr. Chug. Kuo Chung Y o Tsa Chih, Vol. 17(2), pp. 98 - 100].
  • Betulinic acid a steroidal triterpenoid has been found to possess several pharmacological properties.
  • the cytotoxic activity of betulimc acid and other ellagic acid derivatives from Agrostistachys hookery has been reported [Choi, Y. N., Pezzuto, J. M., Kinghorn, A. D., and Farnsworth, N. R., (1988), Planta Medica, Vol. 54(6), pp. 511 - 513].
  • Topical application of l ⁇ g of 12 - O - tetradecanoyl phorbol -.13 - acetate (TPA) to the ears of mice was shown to induce oedema and this TPA induced inflammation was inhibited by 4 - methyl sterol and triterpene derivatives.
  • the inhibitory effects of sterol and triterpene derivatives including betulinic acid on TPA - induced inflammation roughly paralleled their inhibitory activities against tumor promotion [Yasukawa, K., Takidom, M., Matsu oto, T., Takeuchi, M., Nakagawa, S., (1991), Oncology, Vol. 48(1), pp. 72 - 76].
  • Betulinic acid and platonic acid isolated from the leaves Syzigium calviforum were found to be inhibitors of HIV replication in H9 lymphocyte cells. Evaluation of anti-HTV activity with eight derivatives of betulinic acid revealed that dihydro-betulinic acid was also a potent inhibitor of HTV replication; the C-3 hydroxy group of C-17 carboxylic acid group, as well as the C-19 substituents, contribute to enhance the anti-HTV activity [Fujioka, T., Kashiwada, Y., Lee, K. H, (1994), J. Natural Product, Vol. 57(2), pp. 243 - 247].
  • HTV - 1 human immunodeficiency virus type 1
  • Plant constituents such as taxol, camptothecin, podophyllotoxin, vinblastine and vincristine represent some of the most important drugs currently used for the treatment of human cancers. They are structurally complex and capable of facilitating unique mechanisms of cytotoxicity like necrosis or apoptosis. These lead compounds have been used as models for development of anti-cancer chemotherapeutic drugs.
  • Betulinic acid isolated from the stem bark of Ziziphus mauritiana Lam., (Rhamnaceae) (white birch trees) has been found to be active as a selective inhibitor of human melanoma which acts by induction of apoptosis as a melanoma specific cytotoxic agent [Pisha, E., Chai, H., Lee, I.S., Chagentréea, T. E., Farnsworth, N. R., Cordell, G. A, Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., Wani, M. C, Wall, M. E., Hieken, T. J., Dasgupta, T. K., and Pezzuto, J. M., (1995), Nature Medicine, Vol. 1(10), pp. 1046 - 1051].
  • the main object of the invention is to provide a process for the isolation of betulinic acid useful as anti-HTV, anti-tumoral and melanoma specific cytotoxic agent.
  • nucifera such as leaves, stalks, flowers and seeds were subjected to phyt ' ochemical methods for the isolation of betulinic acid with little success. It was noted that the rhizome showed the presence of substantial amounts of betulinic acid.
  • the present invention provides a process for the isolation of betulinic acid which comprises extracting rhizomes of Nelumbo nucifera Gaertn (Family - Nymphaeaceae) with a polar solvent at a temperature in the range of 50 - 60°C by conventional soxhlet extraction methods, concentrating the extracts at a pressure in the range of 30 - 50 mm Hg, adding water to the above said concentrate residue, extracting the said residue successively with non-polar solvents, extracting the aqueous phase with organic solvent, concentrating the above obtained organic solvent phase and purifying the product by conventional methods such as column chromatography followed by crystallization to give pure betulinic acid.
  • the polar solvents used for extraction are selected from the group consisting of methanol, ethanol, butanol, propanol, dimethyl formamide and dimethyl sulphoxide.
  • the non-polar solvent used is selected from petroleum ether (b.p. 40 - 60°C), petroleum ether (b.p. 60 - 80°C), carbon tetrachloride, heptane and benzene.
  • the organic solvent used for the final extraction are selected from the group consisting of chloroform, methanol and any mixture thereof.
  • the rhizomes fo the plant N. nucifera Gaertn were collected form Sandhipur, Midnapore district of West Bengal, India. Taxonomic identification of the plant was performed by Dr. D. C. S, Raju of Botanical Survey of India, Shibpur, Howrah. A voucher specimen (N-21) is being maintained in the laboratory for future reference.
  • the rhizomes were sliced into small pieces, dried, pulverized by a mechanical grinder, passed through a 40 mesh sieve and stored in a well closed container for extraction. Extraction and isolation;
  • the dried powder rhizome of the plant was extracted with methanol in a soxhlet extractor. After evaporation of the solvent from the extract, a brown coloured dry mass was obtained which was taken in a small amount of water and extracted successively with petroleum ether (b.p. 60 - 80°C) and benzene.
  • the aqueous phase of the benzene extract was acidified using 2M sulphuric acid upto pH 5 - 5.5 and extracted with chloroform. This was concentrated under vacuum to dryness and subjected to chromatographic separation of silica gel (60 - 120 mesh) column (20 x 5.5 cm).
  • the dried powdered rhizomes was again extracted with ethyl alcohol (95 % v/v) and same procedure was adopted. The amount of betulinic acid obtained was relatively less.
  • the dried powdered rhizomes was also extracted with petroleum ether (b.p. 40 - 60°C and 60 - 80°C), benzene, n-hexane, propanol, butanol, separately concentrated under reduced pressure and the concentrated mass was subjected to column chromatographic separation as described above. Pentacyclic triterpene like betulinic acid was not separated by these methods.
  • the NMR spectrum showed a 15 proton multiplet ranging from ⁇ 8.77 - 9.16 which accounts for five methyl groups.
  • the methyl group of the isopropenyl function resonates as a triplet centered at ⁇ 8.18 and the proton on the hydroxyl bearing carbon resonates as a triplet centered at ⁇ 6.53 suggesting that this carbon is adjacent to a single methylene group.
  • Mass spectrum of the isolated substance showed principal peaks at m/z 456 (M), 438 (m - 18), 423 (M-33), 406 (M-50) and the peaks in the mass range of 190 - 250 were m/z 248, 220, 219, 207, 203 and 1S9. [ ] 23 + 7.9° (c.
  • betulinic acid as provided above as formula I, it is clear that betulinic acid, the therapeutically active pentacyclic triterpenoid embodying the invention is shown by way of illustration only and not as a limitation of the invention.
  • the principal features of the invention may be employed in respect of various other plant species for isolation of the pentacyclic triterpene betulinic acid without departing from the scope of the invention.
  • Rhizomes were collected, dried under shade, pulverized by mechanical grinder and passed through a 40 mesh sieve.
  • Powdered rhizomes were extracted with methanol (b.p. 65°C) in a soxhlet extractor for successive 48 hours with constant supply of heat (temperature 60 - 65°C) by a heating mantle.
  • the aqueous phase (pH 5.5 - 6) was further extracted with chloroform.
  • This extract was subjected to column chromatographic separation over silica gel (60 - 120 mesh) column and eluted with a solvent system comprising chloroform:methanol (1:1).
  • Crystalline precipitate separated out which was filtered through Whatman filter paper No. 1, and dried in air.
  • the product was recrystallised from methanol by treating with activated charcoal.
  • the white needle shaped crystalline material was characterized by studying its different physico-chemical characteristics such as melting point, UV, IR, NMR, mass spectral characteristics and compared with values reported in the art and with an authenticated sample of betulinic acid. The data showed the compound to be betulinic acid.
  • Example 1 is illustrative and should not be construed to limit the scope of the invention.
  • the recrystallised material was found to be a white needle shaped crystalline material which when subjected to study of characteristics such as UV, TR, NMR, mass spectra characteristics and compared with values for an authenticated sample of betulinic acid was identified as betulinic acid (C30H48O3). 1000 gm of powdered rhizome yielded 6.25 gm of isolated crystalline betulinic acid.
  • the process of the present invention provides a therapeutically effective pentacyclic triterpene betulinic acid in good yield (0.53 - 0.60 % w/w with respect to dry powdered rhizomes).
  • This compound is reported to have potent anti-HTV, anti-tumoral and human melanoma specific cytotoxic acitivity.
  • a pentacyclic triterpenoid betulinic acid is isolated from a commonly occurring plant N. nucifera Gaertn (Family - Nymphaeaceae).
  • the process of the invention provides a good yield and is economical.
  • the process of the invention is useful for the isolation of compounds similar to betulinic acid from the vast resources of medicinal plants in India.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for the isolation of betulinic acid by extracting rhizomes of Nelumbo nucifera Gaertn (Family - Nymphaeaceae) with a polar solvent by conventional soxhlet extraction methods, concentrating the extract, adding water to the concentrated residue, extracting the said residue successively with non-polar solvents, extracting the aqueous phase with organic solvent, concentrating the above obtained organic solvent phase and purifying the product by conventional methods such as column chromatography followed by crystallization to give pure betulinic acid.

Description

A PROCESS FOR THE ISOLATION OF BETULINIC ACID FROM NELUMBO NUCIFERA GAERTN RHIZOMES
Field of the invention
The present invention relates to a process for the isolation of betulinic acid. More particularly, the present invention relates to a process for the isolation of betulinic acid from Nelumbo nυcifera Gaertn. (Family Nymphaeaceae). The acid thus obtained has potent therapeutic activity and is useful as anti-HIV, anti-tumoral and melanoma specific cytotoxic agent. Background of the invention
Nelumbo nucifera Gaertn. (Family Nymphaeaceae) is a large aquatic herb with slender elongate, branched creeping stems and stout creeping yellowish white coloured rhizomes. The flower of Nelumbo nucifera Gaertn. is the national flower of India. Almost all parts of this plant are used in Indian Traditional Medicine to cure several diseases [Chopra, R. N., Chopra I. C, and Handa, K. L. (1958), Indigenous Drugs of India, 2nd ed., U. N. Dhur & Sons Pvt. Ltd., Calcutta, p. 679; Kirtikar, K. R, and Basu, B. D., (1975) in Indian Medicinal Plants ed. by Blatter, E., Caius, J. E., and Mhasker, K. S., Bishen Singh and Mahendra Pal Singh, Dehradun, pp. 116 - 120; Nadkarni, A. K., (1992) Indian Materia Medica, Vol. I, Popular Prakashan, Bombay, pp. 845 - 846]. Evaluation of different therapeutic potentials like the hypoglycaemic [Mukherjee, P. K., Pal,-S. K., Saha, K., and Saha, B. P., Phytotherapy Research, 1995, Vol. 9, pp. 522 - 524], antibacterial rMukherjee, P. K:5 Balasubramaniam, R., Saha K., Pal, M. and Saha B. P., Indian Drugs, 1995, Vol. 32(6), pρ.274 - 276], antifungal [Mukherjee, P. K., Giri, S. N., Saha, K., Pal, M., and Saha, B. P., Indian J. Microbiology, 1995, Vol. 35(4), pp.327 - 330], diuretic [Mukherjee, P. K., Das, J„ Saha K., Pal, M., and Saha, B. P., Phytotherapy Research, 1996, Vo. 10, pp. 424 - 425], psychopharmacological [Mukherjee, P. K., Balasubramaniam, R., Pal, M. and Saha, B. P., Journal of Ethnopharmacology, 1996,Vol. 54 (2,3), 63 - 67], antipyretic [Mukherjee, P. K., Saha K., Das, J., Giri, S. N., Pal, M. and Saha, B. P., Indian J. Experimental Biology, 1996, Vol. 82(6), pp. 274 - 276], anti-diarrhoeal [Mukherjee, P. K., Das, J., Balasubramaniam, R., Saha K., Pal, M. and Saha, B. P., Indian J. Pharmacology, 1995, Vol. 27, pp. 262 - 264] effects of the rhizome N. nucifera have been investigated.
Betulinic acid has been isolated and identified from several plant species. The hexane extract of Picramnia pentandra showed the presence of 3 - epi-betulinic acid [Herz, W., Santhanam, P. S., and Wahlberg, I., (1972), Phytochemistry, Vol. 11, pp. 3061 - 3063]. The plants Lemaireocereus stellatus, L. pruinosus, Machaereocereus eruca have been found to contain oleanolic acid, betulinic acid and machaeric acid (21 - keto-oleanolic acid) [Djerassi, C, Liu, L. H., Farkar, E., Lippman, A. E., Lennin, A. J., McDonald, R. N., and Taylor, B. J., (1995), J. Am. Chem. Soc, Vol. 77, pp. 1200 - 1203]. 3-epi-betulinic acid along with three other triterpene glycosides were isolated from leaves of Schefflera cotophylla (Lour) Harms (Family - Araliaceae) [Sung, T. V., Steglich, W., and Adam, G., (1991), Phytochemistry, Vol. 30(7), pp. 2349 - 2356]. Oleanolic acid, betulin, betulinic acid, erythrodiol, maniladiol and several other triterpenes have been isolated from cactus species along with some other cactus triterpenes such as longispinogenin, gummosogenin and cochalic acid, all belonging to the Cactaceae family. Oleanolic acid and betulinic acid have also been isolated from several plants of the Lemaireocereus specie such as Lemaireocereus quovedonis, L. griseus, L. hystrix, L. treleasei. The occurrence of betulinic acid or betulin in Cactus ox Lemaireocereus speceis is not surprising in view of their evident structural similarity to the cactus triterpenes thurberogenin and stellatogenin [Djerassi, C, Bowers, A., Burstein, S., Estrada, H., Grossman, J., Herran, J., Lennin, A. J., Manjarraz, A., and Pakrashi, S. C, (1956), J. Am. Chem. Soc. Vol. 78, pp. 2312 - 2315]. Seeds of Diospyros montana Roxb produce betulinic acid from the n-hexane soluble fraction of its ethanolic extract [Misra, G., Nigam, S. K., and Mitra C. R., (1972), Phytochemistry, Vol. 11, pp. 1508 - 1509], Bark of Arbutus menziesii (Family - Ericaceae) produce betulinic acid from the acetic acid insoluble solid of the alkaloidal extractives produced from this plant [Robinson, F. P., and Martel, H., (1970), Phytochemistry, Vol. 9, pp. 907 - 909]. The extractives of the barks and leaves of Alphitonia excelsa, A. petriel and A. whitei and of the wood, bark and leaves of A. macrocarpa are reported to possess triterpenes like betulinic acid, ceanothic acid and alphitolic acid [Branch, G. B., Buragers, D. V., Dunstan, P. J., Foo, L. Y., Green, G. H., Mack, J. P. G., Ritchie, E, and Taylor, W. C, (1972), Aust. J. Chem., Vol. 25, pp. 2209 - 2216]. The bark of Akania luceus (commonly known as 'turnip wood') has been found to contain betulinic acid, betulonic acid and 3— desoxy betulonic acid [Krajniak, E., Ritchie, E., and Taylor, W. C, (1969), Aust. J. Chem., Vol. 22, ppl331 - 1332]. The trunk wood of Caraipa grandifolia Mart (Family - Guttiferae) contains sitosterol, lupeol, lupenone, betulinic acid and vanillin. The trunk wood of C. densiflora Mart contains sitosterol, lupeol, friedelin, betulinic acid and vanillin [Alves De Lima, R., and Gottlieb, O. R., (1972), Phytochemistry, Vol. 11, pp. 2307 - 2309]. Betulinic acid and ursolic acid have been isolated from Hedyotis chrystoricha (Palib) Merr [Fang, Z., Yang, Y., and Zhou, G., (1992), Merr. Chug. Kuo Chung Y o Tsa Chih, Vol. 17(2), pp. 98 - 100].
Betulinic acid a steroidal triterpenoid has been found to possess several pharmacological properties. The cytotoxic activity of betulimc acid and other ellagic acid derivatives from Agrostistachys hookery has been reported [Choi, Y. N., Pezzuto, J. M., Kinghorn, A. D., and Farnsworth, N. R., (1988), Planta Medica, Vol. 54(6), pp. 511 - 513]. Topical application of lμg of 12 - O - tetradecanoyl phorbol -.13 - acetate (TPA) to the ears of mice was shown to induce oedema and this TPA induced inflammation was inhibited by 4 - methyl sterol and triterpene derivatives. The inhibitory effects of sterol and triterpene derivatives including betulinic acid on TPA - induced inflammation roughly paralleled their inhibitory activities against tumor promotion [Yasukawa, K., Takidom, M., Matsu oto, T., Takeuchi, M., Nakagawa, S., (1991), Oncology, Vol. 48(1), pp. 72 - 76].
Betulinic acid and platonic acid isolated from the leaves Syzigium calviforum were found to be inhibitors of HIV replication in H9 lymphocyte cells. Evaluation of anti-HTV activity with eight derivatives of betulinic acid revealed that dihydro-betulinic acid was also a potent inhibitor of HTV replication; the C-3 hydroxy group of C-17 carboxylic acid group, as well as the C-19 substituents, contribute to enhance the anti-HTV activity [Fujioka, T., Kashiwada, Y., Lee, K. H, (1994), J. Natural Product, Vol. 57(2), pp. 243 - 247]. A series of triterpene compounds including betulinic acid characterized by a straight structure activity related relationship were identified as potent and selective inhibitors or human immunodeficiency virus type 1 (HTV - 1) replication. The betulinic acid derivatives showed 50 % inhibitory concentrations (IC 50) against HTV - 1 strain HI B/LAI in the 10 nM range in several cellular infection assayed, but were inactive against HTV - 2. These compounds did not significantly inhibit the in vitro activities of several purified HTV - 1 enzymes; rather they appeared to block virus infection at a post-binding, envelope dependant step involved in the fusion of the virus to the cell membrane [Mayaux, J. F., Bousseall, A., Pauwels, R., Huet, T., and Henin, Y., (1994), Proc. Natl. Acad, Sc , Vol. 91, pp. 3564 - 3568]. Steroidal anti- inflammatory activity of triterpenoids has also been studied. These triterpenes were isolated from Diospyros leucomelas and identified as betulin, betulinic acid and ursoic acid. They showed anti-inflammatory activity in the carrageenan and serotonin paw oedema test and TPA and EPP ear oedema tests [Recio, M. C, Giner, R. M., Manez, S., Gueno, J., Julien, H. R., Hostet mann, K., and Rios, J. L., (1995), Planta Medica, Vol. 61, pp. 9 - 12].
Plant constituents such as taxol, camptothecin, podophyllotoxin, vinblastine and vincristine represent some of the most important drugs currently used for the treatment of human cancers. They are structurally complex and capable of facilitating unique mechanisms of cytotoxicity like necrosis or apoptosis. These lead compounds have been used as models for development of anti-cancer chemotherapeutic drugs. Betulinic acid isolated from the stem bark of Ziziphus mauritiana Lam., (Rhamnaceae) (white birch trees) has been found to be active as a selective inhibitor of human melanoma which acts by induction of apoptosis as a melanoma specific cytotoxic agent [Pisha, E., Chai, H., Lee, I.S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A, Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., Wani, M. C, Wall, M. E., Hieken, T. J., Dasgupta, T. K., and Pezzuto, J. M., (1995), Nature Medicine, Vol. 1(10), pp. 1046 - 1051].
It is therefore important to develop processes for the isolation of triterpenes such as betulinic acid from new and easily available natural sources in a cost effective manner in view of its high utility. Objects of the invention
The main object of the invention is to provide a process for the isolation of betulinic acid useful as anti-HTV, anti-tumoral and melanoma specific cytotoxic agent.
It is another object of the present invention to provide a process for the isolation of betulinic acid from Nelumbo nucifera Gaertn (Family - Nymphaeaceae) in good yield (0.60% w/w with respect to the dry powdered material) and in a cost effective manner. Summary of the invention
It has been found that the rhizome of the plant N. nucifera contains a substantial amount of the pentacyclic triterpenoid, betulinic acid of the general formula
Figure imgf000005_0001
This can be prepared in good yield in an environmentally acceptable manner using a soxhlet extractor and column chromatography and crystallization technique and characterized thereafter. While other parts of the plant were also studied it was observed that the presence of betulinic acid in such parts was minimal or absent.
While different alkaloids and glycosides like nelumbin, nuciferine, nor-nuciferine has been reported from the leaves, flowers and stalks of this plant, there is no report on the chemical constituents of the rhizome so far. The rhizome has been found to contain a good quality of starch, which has potential binding and disintegrating property which can be effectively used in tablet technology [Mukherjee, P. K., Giri, S. N., Saha, K., Pal, M., and Saha, B. P., (1995) Indian Drugs, Vol. 32(8), pp. 392 - 397; Mukherjee, P. K., Giri, S. N., Saha, K., Pal, M., and Saha, B. P., (1996), Indian J. Pharmaceutical Science, Vol. 58(2), pp. 59 - 66]. While proceeding with its chemical identity the methanolic extract of N. nucifera has been found to contain a steroidal triterpenoid, betulinic acid.
The identity of the isolated compound was decided by comparing its spectral data (UV, IR, 1HΝMR, Mass) to values reported earlier [Davy, G. S., Halsall, T. G., and Jones, E. R. H, (1951), J. Chem. Soc, pp. 2696 - 2702; Djerassi, C, Bowers, A, Burstein, S., Estrada, H, Grossman, J., Herran, J., Lennin, A. J., Manjarraz, A., and Pakrashi, S. C, (1956), J. Am. Chem. Soc, Vol. 78, pp. 2312 - 2315; Sung, T. V., Steglich, W., and Adam, G., (1991), Phytochemistry, Vol. 30(7), pp. 2349 - 2356; Misra, G., Νigam, S. K., and Mitra C. R., (1972), Phytochemistry, Vol. 11, pp. 1508 - 1509; Pakrashi, S. C, Bhattacharya, J., Mookherjee, S., and Samanta, T. B., (1968), Phytochemistry, Vol. 7, pp. 461 - 466], TLC comparison with authentic sample, and also by observing the mixed melting point with authentic sample. Other parts of N. nucifera such as leaves, stalks, flowers and seeds were subjected to phyt'ochemical methods for the isolation of betulinic acid with little success. It was noted that the rhizome showed the presence of substantial amounts of betulinic acid.
Accordingly, the present invention provides a process for the isolation of betulinic acid which comprises extracting rhizomes of Nelumbo nucifera Gaertn (Family - Nymphaeaceae) with a polar solvent at a temperature in the range of 50 - 60°C by conventional soxhlet extraction methods, concentrating the extracts at a pressure in the range of 30 - 50 mm Hg, adding water to the above said concentrate residue, extracting the said residue successively with non-polar solvents, extracting the aqueous phase with organic solvent, concentrating the above obtained organic solvent phase and purifying the product by conventional methods such as column chromatography followed by crystallization to give pure betulinic acid.
In one embodiment of the invention, the polar solvents used for extraction are selected from the group consisting of methanol, ethanol, butanol, propanol, dimethyl formamide and dimethyl sulphoxide.
In another embodiment of the invention, the non-polar solvent used is selected from petroleum ether (b.p. 40 - 60°C), petroleum ether (b.p. 60 - 80°C), carbon tetrachloride, heptane and benzene. In another embodiment of the invention, the organic solvent used for the final extraction are selected from the group consisting of chloroform, methanol and any mixture thereof.
Detailed description of the invention Plant material:
The rhizomes fo the plant N. nucifera Gaertn were collected form Sandhipur, Midnapore district of West Bengal, India. Taxonomic identification of the plant was performed by Dr. D. C. S, Raju of Botanical Survey of India, Shibpur, Howrah. A voucher specimen (N-21) is being maintained in the laboratory for future reference. The rhizomes were sliced into small pieces, dried, pulverized by a mechanical grinder, passed through a 40 mesh sieve and stored in a well closed container for extraction. Extraction and isolation;
The dried powder rhizome of the plant was extracted with methanol in a soxhlet extractor. After evaporation of the solvent from the extract, a brown coloured dry mass was obtained which was taken in a small amount of water and extracted successively with petroleum ether (b.p. 60 - 80°C) and benzene. The aqueous phase of the benzene extract was acidified using 2M sulphuric acid upto pH 5 - 5.5 and extracted with chloroform. This was concentrated under vacuum to dryness and subjected to chromatographic separation of silica gel (60 - 120 mesh) column (20 x 5.5 cm). Elution with the solvent system chloroform: methanol (1:1) afforded a light yellow coloured fraction which when kept under refrigeration showed crystalline precipitate. This was recrystallised from methanol to provide a white needle shaped crystalline material in yields of 0.60 % w/w with respect to the dry powdered rhizomes.
The dried powdered rhizomes was again extracted with ethyl alcohol (95 % v/v) and same procedure was adopted. The amount of betulinic acid obtained was relatively less. The dried powdered rhizomes was also extracted with petroleum ether (b.p. 40 - 60°C and 60 - 80°C), benzene, n-hexane, propanol, butanol, separately concentrated under reduced pressure and the concentrated mass was subjected to column chromatographic separation as described above. Pentacyclic triterpene like betulinic acid was not separated by these methods.
The crystalline compound obtained from the methanolic extract of N. nucifera rhizome has melting point: 276 - 278°C, UV γmax nm: 223, 420; IR λmaxcm"1: 1692 (>C = 0), 3452 (OH), 2940, 1644 and 885 (terminal methylene group); 'HΝMR (IOOMHZ, CdCL3, TMS as international standard): δ 4.77 (IH, d, j = 1.5 Hz, H - 29b), 4.60 (IH, d, j = 1.5 Hz, H - 29a), 3.39 (IH, d, j = 10.8 Hz, H- 27b), 3.00 (H, dd,j = 5.4, 4.3 Hz, H- 3), 1.7 (3H, s, H- 30). The NMR spectrum showed a 15 proton multiplet ranging from τ 8.77 - 9.16 which accounts for five methyl groups. The methyl group of the isopropenyl function resonates as a triplet centered at τ 8.18 and the proton on the hydroxyl bearing carbon resonates as a triplet centered at τ 6.53 suggesting that this carbon is adjacent to a single methylene group. Mass spectrum of the isolated substance showed principal peaks at m/z 456 (M), 438 (m - 18), 423 (M-33), 406 (M-50) and the peaks in the mass range of 190 - 250 were m/z 248, 220, 219, 207, 203 and 1S9. [ ]23 + 7.9° (c. 0.057, pyridine), The IR, NMR, and mass spectra of the isolated compound were identical with those of an authenticated sample of betulinic acid (found: C, 78.90; H, 10.53% Calc. for C30H48O3: C, 78.90; H, 10.59%).
From the structure of betulinic acid as provided above as formula I, it is clear that betulinic acid, the therapeutically active pentacyclic triterpenoid embodying the invention is shown by way of illustration only and not as a limitation of the invention. The principal features of the invention may be employed in respect of various other plant species for isolation of the pentacyclic triterpene betulinic acid without departing from the scope of the invention.
The steps involved in the isolation of betulinic acid from the rhizome of the N. nucifera are given below:
Rhizomes were collected, dried under shade, pulverized by mechanical grinder and passed through a 40 mesh sieve.
I
Powdered rhizomes were extracted with methanol (b.p. 65°C) in a soxhlet extractor for successive 48 hours with constant supply of heat (temperature 60 - 65°C) by a heating mantle.
I After complete extraction, the extract so obtained was concentrated under reduced pressure (30mm Hg) and at a temperature of 35°C, pH of which was adjusted to 5 by addition of 2M sulphuric acid. i The extract was successively extracted with petroleum ether and benzene.
1
The aqueous phase (pH 5.5 - 6) was further extracted with chloroform.
I The chloroform extract was concentrated under vacuum to 1/10th of the original extract volume.
I
This extract was subjected to column chromatographic separation over silica gel (60 - 120 mesh) column and eluted with a solvent system comprising chloroform:methanol (1:1).
I
Light yellow coloured eluant separated from column and was refrigerated (4°C) for 24 hours.
I
Crystalline precipitate separated out which was filtered through Whatman filter paper No. 1, and dried in air.
The product was recrystallised from methanol by treating with activated charcoal.
I
White needle shaped crystalline material separated out.
The white needle shaped crystalline material was characterized by studying its different physico-chemical characteristics such as melting point, UV, IR, NMR, mass spectral characteristics and compared with values reported in the art and with an authenticated sample of betulinic acid. The data showed the compound to be betulinic acid.
The following examples are illustrative and should not be construed to limit the scope of the invention. Example 1
200 gm of powdered rhizome of N. nucifera was extracted with methanol for 48 hours in a soxhlet extractor at a temperature of 60°C. The methanol extract was concentrated under reduced pressure, mixed with 10 ml of water and extracted successively with petroleum ether (b. p. 60 - 80°C) and benzene. The aqueous phase after benzene extraction was further extracted with chloroform and this chloroform extract was concentrated under reduced pressure. This extract was passed through a silica gel (60 -120 mesh) column (20 x 5.5 cm) and eluted with a solvent system chloroforrmmethanol (1:1). A yellowish coloured compound eluted out which after collection was concentrated to half its volume and refrigerated for 24 hours at.4°C. A yellow coloured crystalline compound separated out which was filtered through a Whatman filter paper No. 1 and recrystallised from methanol after treatment with activated charcoal. The recrystallised material was found to be a white needle shaped crystalline material which when subjected to study of characteristics such as UV, TR, NMR, mass spectra characteristics and compared with values for an authenticated sample of betulinic acid was identified as betulinic acid (C30H48O3). 200 gm of powdered rhizome yielded 1.125 gm of isolated crystalline betulinic acid. Example 2
400 gm of powdered rhizome of N. nucifera was extracted with methanol for 48 hours in a soxhlet extractor at a temperature of 60°C. The methanol extract was concentrated under reduced pressure, mixed with 10 ml of water and extracted successively with petroleum ether (b. p. 60 - 80°C) and benzene. The aqueous phase after benzene extraction was further extracted with chloroform and this chloroform extract was concentrated under reduced pressure. This extract was passed through a silica gel (60 -120 mesh) column (20 x 5.5 cm) and eluted with a solvent system chloroform:methanol (1:1). A yellowish coloured compound eluted out which after collection was concentrated to half its volume and refrigerated for 24 hours at 4°C. A yellow coloured crystalline compound separated out which was filtered through a Whatman filter paper No. 1 and recrystallised from methanol after treatment with activated charcoal. The recrystallised material was found to be a white needle shaped crystalline material which when subjected to study of characteristics such as UV, R, NMR, mass spectra characteristics and compared with values for an authenticated sample of betulinic acid was identified as betulinic acid (C30H48O3). 400 gm of powdered rhizome yielded 2.90 gm of isolated crystalline betulinic acid. Example 3
1000 gm of powdered rhizome of N. nucifera was extracted with methanol for 48 hours in a soxhlet extractor at a temperature of 60°C. The methanol extract was concentrated under reduced pressure, mixed with 10 ml of water and extracted successively with petroleum ether (b. p. 60 - 80°C) and benzene. The aqueous phase after benzene extraction was further extracted with chloroform and this chloroform extract was concentrated under reduced pressure. This extract was passed through a silica gel (60 -120 mesh) column (20 x 5.5 cm) and eluted with a solvent system chloroform:methanol (1:1). A yellowish coloured compound eluted out which after collection was concentrated to half its volume and refrigerated for 24 hours at 4°C. A yellow coloured crystalline compound separated out which was filtered through a Whatman filter paper No. 1 and recrystallised from methanol after treatment with activated charcoal. The recrystallised material was found to be a white needle shaped crystalline material which when subjected to study of characteristics such as UV, TR, NMR, mass spectra characteristics and compared with values for an authenticated sample of betulinic acid was identified as betulinic acid (C30H48O3). 1000 gm of powdered rhizome yielded 6.25 gm of isolated crystalline betulinic acid.
The process of the present invention provides a therapeutically effective pentacyclic triterpene betulinic acid in good yield (0.53 - 0.60 % w/w with respect to dry powdered rhizomes). This compound is reported to have potent anti-HTV, anti-tumoral and human melanoma specific cytotoxic acitivity. Advantages of the invention
1. A pentacyclic triterpenoid betulinic acid is isolated from a commonly occurring plant N. nucifera Gaertn (Family - Nymphaeaceae).
2. The process of the invention provides a good yield and is economical.
3. The process of the invention is useful for the isolation of compounds similar to betulinic acid from the vast resources of medicinal plants in India.

Claims

We claim:
1. A process for the isolation of betulinic acid comprising extracting rhizomes of Nelumbo nucifera Gaertn (Family - Nymphaeaceae) with a polar solvent at a temperature in the range of 50 - 60°C by conventional soxhlet extraction methods, concentrating the extract so obtained at a pressure in the range of 30 - 50 mm Hg, adding water to the concentrated residue, extracting the said residue successively with non-polar solvents, extracting the aqueous phase with organic solvent, concentrating the above obtained organic solvent phase and purifying the product by conventional methods such as column chromatography followed by crystallization to give pure betulinic acid.
2. A process as claimed in claim 1 wherein the polar solvent used for extraction is selected from the group consisting of methanol, ethanol, butanol, propanol, dimethyl formamide and dimethyl sulphoxide.
3. A process as claimed in claim 1 wherein the non-polar solvent used is selected from petroleum ether (b.p. 40 - 60°C), petroleum ether (b.p. 60 - 80°C), carbon tetrachloride, heptane and benzene.
4. A process as claimed in claim 1 wherein the organic solvent used for the final extraction is selected from the group consisting of chloroform, methanol and any mixture thereof.
PCT/IN2001/000142 2001-08-03 2001-08-03 A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes WO2003011891A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000142 WO2003011891A1 (en) 2001-08-03 2001-08-03 A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000142 WO2003011891A1 (en) 2001-08-03 2001-08-03 A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes

Publications (1)

Publication Number Publication Date
WO2003011891A1 true WO2003011891A1 (en) 2003-02-13

Family

ID=11076371

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2001/000142 WO2003011891A1 (en) 2001-08-03 2001-08-03 A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes

Country Status (1)

Country Link
WO (1) WO2003011891A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011064710A1 (en) 2009-11-30 2011-06-03 University Of Kwazulu-Natal In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives
WO2013160881A1 (en) 2012-04-26 2013-10-31 Universidade De Aveiro Method for obtaining an extract rich in triterpenic acids from eucalyptus barks
CN112521441A (en) * 2020-12-29 2021-03-19 江西省科学院应用化学研究所 Method for separating and purifying betulinic acid from lotus seedpod shells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MUKHERJEE, PULOK K. ET AL: "Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera", PLANTA MED. (1997), 63(4), 367-369, XP008001367 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011064710A1 (en) 2009-11-30 2011-06-03 University Of Kwazulu-Natal In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives
US8685469B2 (en) 2009-11-30 2014-04-01 University Of Kwazulu-Natal In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives
WO2013160881A1 (en) 2012-04-26 2013-10-31 Universidade De Aveiro Method for obtaining an extract rich in triterpenic acids from eucalyptus barks
CN112521441A (en) * 2020-12-29 2021-03-19 江西省科学院应用化学研究所 Method for separating and purifying betulinic acid from lotus seedpod shells
CN112521441B (en) * 2020-12-29 2021-09-28 江西省科学院应用化学研究所 Method for separating and purifying betulinic acid from lotus seedpod shells

Similar Documents

Publication Publication Date Title
Mukherjee et al. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera
Patocka Biologically active pentacyclic triterpenes and their current medicine signification
Tijjani et al. Isolation and characterization of lup-20 (29)-ene-3, 28-diol (Betulin) from the stem-bark of Adenium obesum (Apocynaceae)
Aguirre et al. Topical anti-inflammatory activity of 2α-hydroxy pentacyclic triterpene acids from the leaves of Ugni molinae
Wadouachi et al. Triterpenes and steroids from the stem bark of Gambeya boiviniana Pierre
Aziz Studies on the chemical constituents of Thymus serpyllum
Suresh et al. Phytochemical potential of Annona reticulata roots for antiproliferative activity on human cancer cell lines
El Deeb et al. Phytochemical and pharmacological studies of Maytenus forsskaoliana
De Felice et al. New polyhydroxylated triterpenes and anti-inflammatory activity of Salvia hierosolymitana
Sharma et al. A new aliphatic acid from Achyranthes aspera Linn. roots
Mallavadhani et al. Diospyros melanoxylon leaves: a rich source of pentacyclic triterpenes
WO2003011891A1 (en) A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes
Pérez Gutiérrez Anti-inflammatory effect of birsonimadiol from seeds of Byrsonima crassifolia
Sawale et al. Antioxidant properties of cycloartenol isolated from Euphorbia neriifolia leaves
Ageta et al. Chemotaxonomy of ferns, 3. Triterpenoids from Polypodium polypodioides
Akhtar et al. Pentacyclic triterpenes from the stem bark of Mimusops elengi L.
Bhat et al. Isolation & characterisation of beta-sitosterol from the rhizomes of Arisaema utile and its evaluation for antioxidant activity
Khedr et al. Phytochemical and biological screening of the leaves of Ficus pandurata Hance. Cultivated in Egypt
Ahmed et al. Triterpenoid antioxidant agents found in Holoptelea integrifolia (Roxb) Planch
Sultana et al. Phytochemical studies on Alstonia scholaris
Rao et al. Chemical examination and biological studies on the bark of Crataeva nurvala Buch.-Ham.
Migas et al. Isoprene derivatives from the leaves and callus cultures of Vaccinium corymbosum var. bluecrop
Dutta et al. Chemical constituents from Sarcostemma acidum (Roxb.) Voigt
Ngadjui et al. Thomandertriol, a triterpenoid from the twigs of Thomandersia laurifolia
Ali Lupene Triterpenoids from the Stem Bark of Albizia lebbeck, Leaves of Leptospermum scoparium and Roots of Nardostachys jatamansi

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EE ES FI GB GD GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ PL PT RO RU SD SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZW AM AZ BY KG KZ MD TJ TM AT BE CH CY DE DK ES FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP